Brooks Laboratories trades jubilantly as its arm gets marketing authorization in UK by MHRA
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Brooks Laboratories is currently trading at Rs. 95.90, up by 14.10 points or 17.24% from its previous closing of Rs. 81.80 on the BSE.
The scrip opened at Rs. 81.30 and has touched a high and low of Rs. 98.15 and Rs. 80.75 respectively. So far 35938 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 155.00 on 16-Sep-2021 and a 52 week low of Rs. 70.00 on 12-May-2022.
Last one week high and low of the scrip stood at Rs. 98.15 and Rs. 78.35 respectively. The current market cap of the company is Rs. 238.38 crore.
The promoters holding in the company stood at 66.41% and Non-Institutions held 33.59%.
Brooks Laboratories’ subsidiary -- Brooks Steriscience has received marketing authorization in UK by MHRA (Medicines and Healthcare products Regulatory Agency). The said marketing authorization is for Meropenem injection 1 gm and 500 mg.
Brooks Laboratories is a pharmaceutical contract research and manufacturing services company.
